0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

Real world consumer segmentation
July 16, 2018
The role of consumer segmentation in Pharma Marketing

As its brand planning season in the Pharmaceutical world it is a useful time to reflect on how this process can be used to deliver a “patient centric” orientation. Do you have adequate knowledge of the patient? Consumer segmentation can inform on patient behaviours and norms to drive incremental growth opportunities for Pharma Marketeers. The world has moved on and brand interactions are no longer only with physicians, in the modern world with multi channel, multi-format communications an engagement strategy is essential in a commercial marketing plan. Whilst there is a lot of effort & time put behind segmenting Physicians from their behaviours, there is also a job to be done on getting under the skin of healthcare consumers and patients, understanding how they use medicines in the real world.

At a brand level there are stages that can be taken to plan & optimise the insight that can be gained from patient insight:

SITUATION ANALYSIS: Patient journey findings – cross sectional and longitudinal, usage findings, competitor analysis

ENGAGEMENT STRATEGY : both direct and indirect channels

MEASUREMENT: benchmarking to be put in place

TACTICAL PLANNING: touch points, projects

Using consumer segmentation will support the understanding of characteristics for discrete typologies of patients & what their current/future needs will be. Through this information there are clear benefits:

1. Understand what makes healthcare consumers different

2. Identify opportunities from different segments

3. Understand the size and value of attitudinal segments

4. Evaluate effectiveness of messaging or campaigns against segments

5. Personalise messaging and product development

Measurement and benchmarking shouldn’t be an after thought in brand planning , measurement is key to seeing a strategy through once segments have been identified and understood as a framework for driving growth opportunities.

Talking Medicines apply consumer segmentations to real world insights seen through the Medsmart® tool.

Recent Blogs

Appointment of Head of Data Quality

Appointment of Head of Data Quality

Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...

The effect of self-diagnosis on patient outcomes

The effect of self-diagnosis on patient outcomes

The internet is a wonderful place. You can find photos of places you want to visit, maps of your favourite mountain ranges, tutorials on how to bake the perfect birthday cake…the list goes on. In recent years, however, there has been a marked increase in the number of...

Pharma Business International Interview

Pharma Business International Interview

Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry.  The full article can be found here on page 10-11 Tell us about Talking Medicines?...

Tracking Covid vaccine progress through Medsmart®

Tracking Covid vaccine progress through Medsmart®

In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their...